While EGFR overexpression has previously been reported in 25-77% of colorectal carcinomas, we detected EGFR expression in 88.2% of biopsy specimens and in 91.2% of surgical specimens [8, 15, 18]. The gene discussed is EGFR; the disease is colorectal carcinoma.